Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

被引：11
|
作者：
Zuin, Marco [1 ,2 ]
Rigatelli, Gianluca [3 ]
Del Favero, Giuseppe [4 ]
Picariello, Claudio [1 ]
Meggiato, Tamara [4 ]
Conte, Luca [1 ]
Faggian, Giuseppe [5 ]
Zuliani, Giovanni [2 ]
Roncon, Loris [1 ]
机构：
[1] Rovigo Gen Hosp, Dept Cardiol, Rovigo, Italy
[2] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Med Sci, Ferrara, Italy
[3] Rovigo Gen Hosp, Dept Cardiovasc Diag & Endoluminal Intervent, Rovigo, Italy
[4] Rovigo Gen Hosp, Dept Gastroenterol, Rovigo, Italy
[5] Univ Verona, Dept Cardiac Surg, Verona, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷
关键词：
Coronary artery disease; Helicobacter pylori; Cardiovascular prevention; METAANALYSIS;
D O I：
10.1016/j.ijcard.2016.08.320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [41] Effects of Helicobacter pylori Infection and Its Eradication on Lipid Profiles and Cardiovascular Diseases
    Nam, Su Youn
    Ryu, Kum Hei
    Park, Bum Joon
    Park, Sohee
    HELICOBACTER, 2015, 20 (02) : 125 - 132
  • [42] Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model
    Tran, Cuong D.
    Kritas, Stamatiki
    Campbell, Mary A. F.
    Huynh, Hien Q.
    Lee, Su-San
    Butler, Ross N.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (12) : 1424 - 1430
  • [43] Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review
    Sahara, Shu
    Sugimoto, Mitsushige
    Murata, Masaki
    Iwata, Eri
    Kawai, Takashi
    Murakami, Kazunari
    Yamaoka, Yoshio
    Shimoyama, Tadashi
    HELICOBACTER, 2024, 29 (03)
  • [44] Helicobacter pylori Seroprevalence in Patients with Coronary Artery Disease
    Mehmet Kanbay
    Gürden Gür
    Muammer Yücel
    Ugur Yilmaz
    Haldun Muderrisoglu
    Digestive Diseases and Sciences, 2005, 50 : 2071 - 2074
  • [45] Gastric Cancer Prevention through Eradication of Helicobacter pylori Infection: Feasibility and Pitfalls
    Derakhshan, Mohammad H.
    Lee, Yeong Yeh
    ARCHIVES OF IRANIAN MEDICINE, 2012, 15 (11) : 662 - 663
  • [46] Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection
    Lin, Te-Fu
    Wu, Deng-Chyang
    Tsay, Feng-Woei
    Tsai, Kuo-Wang
    Tsai, Tzung-Jiun
    Peng, Nan-Jing
    Kao, Sung-Shuo
    Chen, Wen-Chi
    Chen, Yan-Hua
    Hsu, Ping-, I
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (03) : 233 - 237
  • [47] Association of Helicobacter pylori infection with coronary heart disease
    Pieniazek, P
    Karczewska, E
    Duda, A
    Tracz, W
    Pasowicz, M
    Konturek, SJ
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1999, 50 (05): : 743 - 751
  • [48] Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
    Choi, Youn, I
    Chung, Jun-Won
    Kim, Kyoung Oh
    Kwon, Kwang An
    Kim, Yoon Jae
    Kim, Jung Ho
    Seo, Ja Young
    Park, Dong Kyun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (31) : 5247 - 5258
  • [49] Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia?
    Anagnostis, Panagiotis
    Siolos, Pavlos
    Krikidis, Dimitrios
    Goulis, Dimitrios G.
    Stevenson, John C.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (31) : 3665 - 3671
  • [50] A comparative study on helicobacter pylori infection in peptic ulcer disease patients with or without previous eradication therapy
    Chen, Li-Wei
    Chien, Rong-Nan
    Fang, Kua-Meen
    Yen, Cho-Li
    Chang, Jia-Jang
    Lee, Tsung-Shih
    Liu, Ching-Jung
    Chang, Liang-Che
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2209 - 2211
12345